Logo image of GXU.CA

GOVIEX URANIUM INC (GXU.CA) Stock Fundamental Analysis

TSX-V:GXU - TSX Venture Exchange - CA3837981057 - Common Stock - Currency: CAD

0.035  0 (0%)

Fundamental Rating

2

GXU gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 219 industry peers in the Oil, Gas & Consumable Fuels industry. No worries on liquidiy or solvency for GXU as it has an excellent financial health rating, but there are worries on the profitability. GXU is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

GXU had negative earnings in the past year.
GXU had a negative operating cash flow in the past year.
In the past 5 years GXU always reported negative net income.
GXU had a negative operating cash flow in each of the past 5 years.
GXU.CA Yearly Net Income VS EBIT VS OCF VS FCFGXU.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -5M -10M -15M

1.2 Ratios

Looking at the Return On Assets, with a value of -1042.35%, GXU is doing worse than 90.95% of the companies in the same industry.
GXU's Return On Equity of -1318.51% is on the low side compared to the rest of the industry. GXU is outperformed by 81.90% of its industry peers.
Industry RankSector Rank
ROA -1042.35%
ROE -1318.51%
ROIC N/A
ROA(3y)-15.41%
ROA(5y)-13.24%
ROE(3y)-18.58%
ROE(5y)-16.32%
ROIC(3y)N/A
ROIC(5y)N/A
GXU.CA Yearly ROA, ROE, ROICGXU.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 -5 -10 -15 -20

1.3 Margins

GXU does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GXU.CA Yearly Profit, Operating, Gross MarginsGXU.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023

More info and screens

7

2. Health

2.1 Basic Checks

GXU has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, GXU has more shares outstanding
GXU has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
GXU.CA Yearly Shares OutstandingGXU.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M
GXU.CA Yearly Total Debt VS Total AssetsGXU.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M

2.2 Solvency

Based on the Altman-Z score of -65.39, we must say that GXU is in the distress zone and has some risk of bankruptcy.
GXU has a Altman-Z score of -65.39. This is amonst the worse of the industry: GXU underperforms 87.33% of its industry peers.
GXU has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -65.39
ROIC/WACCN/A
WACCN/A
GXU.CA Yearly LT Debt VS Equity VS FCFGXU.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M

2.3 Liquidity

GXU has a Current Ratio of 2.40. This indicates that GXU is financially healthy and has no problem in meeting its short term obligations.
GXU's Current ratio of 2.40 is amongst the best of the industry. GXU outperforms 83.26% of its industry peers.
A Quick Ratio of 2.40 indicates that GXU has no problem at all paying its short term obligations.
GXU's Quick ratio of 2.40 is amongst the best of the industry. GXU outperforms 84.16% of its industry peers.
Industry RankSector Rank
Current Ratio 2.4
Quick Ratio 2.4
GXU.CA Yearly Current Assets VS Current LiabilitesGXU.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for GXU have decreased strongly by -310.29% in the last year.
EPS 1Y (TTM)-310.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%63.64%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 38.08% on average over the next years. This is a very strong growth
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y50%
EPS Next 2Y22.47%
EPS Next 3Y10.52%
EPS Next 5Y38.08%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GXU.CA Yearly Revenue VS EstimatesGXU.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
GXU.CA Yearly EPS VS EstimatesGXU.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.01 -0.01 0.02 -0.02 0.03

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for GXU. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for GXU. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GXU.CA Price Earnings VS Forward Price EarningsGXU.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GXU.CA Per share dataGXU.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.02 -0.04 -0.06 -0.08 -0.1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.47%
EPS Next 3Y10.52%

More info and screens

0

5. Dividend

5.1 Amount

GXU does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GOVIEX URANIUM INC

TSX-V:GXU (3/7/2025, 7:00:00 PM)

0.035

0 (0%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)11-19 2024-11-19
Earnings (Next)04-23 2025-04-23/amc
Inst Owners28.11%
Inst Owner ChangeN/A
Ins Owners10.29%
Ins Owner ChangeN/A
Market Cap28.44M
Analysts84
Price Target0.23 (557.14%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-25%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 3.86
P/tB 3.86
EV/EBITDA N/A
EPS(TTM)-0.12
EYN/A
EPS(NY)-0.01
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0
BVpS0.01
TBVpS0.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1042.35%
ROE -1318.51%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-15.41%
ROA(5y)-13.24%
ROE(3y)-18.58%
ROE(5y)-16.32%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.4
Quick Ratio 2.4
Altman-Z -65.39
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)296.77%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-310.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%63.64%
EPS Next Y50%
EPS Next 2Y22.47%
EPS Next 3Y10.52%
EPS Next 5Y38.08%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-2.28%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year30.07%
EBIT Next 3Y18.17%
EBIT Next 5Y62.86%
FCF growth 1Y25.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y25.04%
OCF growth 3YN/A
OCF growth 5YN/A